Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions
about
ADHD: an integration with pediatric traumatic brain injuryA common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medicationComorbid Depressive Disorders in ADHD: The Role of ADHD Severity, Subtypes and Familial Psychiatric Disorders.A person-centered personality approach to heterogeneity in attention-deficit/hyperactivity disorder (ADHD).Relative influence of genetics and shared environment on child mental health symptoms depends on comorbidity.Latent profiles of nonresidential father engagement six years after divorce predict long-term offspring outcomes.Clinical utility of the Vanderbilt ADHD diagnostic parent rating scale comorbidity screening scales.Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypesAttention deficit hyperactivity disorder in Australian adults: prevalence, persistence, conduct problems and disadvantageSymptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.Does attention-deficit/hyperactivity disorder have a dimensional latent structure? A taxometric analysis.DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder.A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcomePersonality profiles in adults with attention deficit hyperactivity disorder (ADHD).Retrospective assessment of childhood ADHD symptoms for diagnosis in adults: validity of a short 8-item version of the Wender-Utah Rating Scale.Variation in substance use relapse episodes among adolescents: a longitudinal investigationAnalysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls.Bridging the Communication Divide: A Role for Health Psychology in the Genomic Era.ADHD Symptoms in a Non-Referred Low Birthweight/Preterm Cohort: Longitudinal Profiles, Outcomes, and Associated Features.The association between attention-deficit/hyperactivity (ADHD) symptoms and self-employmentADHD across cultures: is there evidence for a bidimensional organization of symptoms?Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.Academic and Social Functioning Associated with Attention-Deficit/Hyperactivity Disorder: Latent Class Analyses of Trajectories from Kindergarten to Fifth Grade.DSM-IV-defined inattention and sluggish cognitive tempo: independent and interactive relations to neuropsychological factors and comorbidity.Attention-deficit hyperactivity disorder (ADHD) and birth order.Psychiatric disorders in preschoolers: the structure of DSM-IV symptoms and profiles of comorbidity.The ASRS-6 has two latent factors: attention deficit and hyperactivity.Externalizing disorders and substance use: empirically derived subtypes in a population-based sample of adults.Clinical Profiles of Children with Disruptive Behaviors Based on the Severity of Their Conduct Problems, Callous-Unemotional Traits and Emotional Difficulties.Homogeneous Combinations of ASD-ADHD Traits and Their Cognitive and Behavioral Correlates in a Population-Based Sample.Variation in Latent Classes of Adult Attention-Deficit Hyperactivity Disorder by Sex and Environmental Adversity.The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.Analysis of component findings in 79 patients diagnosed with VACTERL association.
P2860
Q22241474-C677634A-7BEC-47E7-AD30-C2EF255F3D6EQ28273217-A0DBB3E7-6F33-42B4-9409-52F48AEFE1FFQ33620351-28233357-778D-4E3C-ADEC-5FA0BFD048ECQ33756970-2A43E28E-EACD-4275-A70A-CD79B73E6BA7Q33982049-93341EC9-6351-4ED7-A82F-64580CE2EFA0Q33983988-EFF53EF2-2148-481B-838A-06418A64D04EQ34255208-2A8DF991-0EE6-48BC-A59E-596F5AFD053AQ34358356-0B119876-56DB-4A1D-80ED-0624E0FE032DQ34448231-44547CDF-2EA6-425E-B783-0F8891EC0463Q34481152-4786CA19-7377-4E95-8E13-5600C44CF035Q34970300-3247D55B-2E3A-497B-995B-A92D651EE028Q35005473-2BDF2B87-6EB6-416C-ACE9-0F0E774894FFQ35844232-9BB33E5D-0547-46AE-AAE4-C3555859FD3BQ36052123-D1CB03A7-207D-4D62-9611-4C43D39D2D0EQ36100589-FCFC6C32-32E9-40BD-8CF3-0F8BFCFD1D65Q36127908-5EC63D32-F06E-4A08-BB5D-55ED43C68D51Q36429012-96B2CC9A-A0A6-44B9-81A9-5490E9391664Q36678417-65A04F7F-6FFE-4439-905C-999DD04BAFBAQ37033911-885E58C0-EFEE-43AC-AF38-01ACB3C28259Q37218341-2D15D874-8566-4B1A-8894-DDADE35E4C35Q37737161-0A076AEE-B8B2-4774-BC8B-E86EA32CA290Q37813630-AB73DA3F-DC05-4253-9BCB-56AF834FE524Q40124565-E5EFAA16-CA82-4858-B6D0-E73CB865D9D5Q43006979-FA7E2977-E239-4F29-8A4A-4DE65803A5B2Q43858500-C009499A-F9DD-4B65-8F4C-2799595AD743Q44122906-32139796-17FF-4456-BC4C-4CD10228506DQ45850447-F7663A18-9FFA-4A3B-BE3C-56E21AC4B962Q46211582-4AC20690-8AFE-4DD3-85D2-31494A211BDAQ47808966-0C648B2F-1978-4690-89FD-950FBFF32F82Q50307025-C4920086-78DB-4282-A03E-4EEF9B916251Q50683828-0573611D-1433-48B5-A699-9F8FE10507A4Q53126759-868E2463-FB87-4C2D-BA71-EE9AE7BE6220Q55289444-95847E9C-7117-424C-89E9-D3BEFE6E230B
P2860
Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Latent class subtyping of atte ...... sorder and comorbid conditions
@en
Latent class subtyping of atte ...... order and comorbid conditions.
@nl
type
label
Latent class subtyping of atte ...... sorder and comorbid conditions
@en
Latent class subtyping of atte ...... order and comorbid conditions.
@nl
prefLabel
Latent class subtyping of atte ...... sorder and comorbid conditions
@en
Latent class subtyping of atte ...... order and comorbid conditions.
@nl
P2093
P2860
P50
P1476
Latent class subtyping of atte ...... sorder and comorbid conditions
@en
P2093
Christopher Sarampote
Heather F Russell
Janet Jones
Joan Z Balog
Luis Palacio
Maria T Acosta
Patricia Eagen
P2860
P304
P356
10.1097/CHI.0B013E318173F70B
P577
2008-07-01T00:00:00Z